The cardiac ryanodine receptor (RyR2) and its role in heart disease

Ying Taur1, William H Frishman

  • 1Department of Medicine, Long Island Jewish Medical Center/Albert Einstein College of Medicine, Manhasset, New York, USA.

Cardiology in Review
|April 16, 2005
PubMed

Insights

The cardiac ryanodine receptor regulates calcium release in heart cells. Dysfunction in heart failure causes calcium leakage, impairing heart function and leading to arrhythmias.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • The cardiac ryanodine receptor (RyR2) is crucial for excitation-contraction coupling in cardiomyocytes.
  • Its dysregulation is implicated in various cardiac diseases, including heart failure and arrhythmias.
  • Understanding RyR2 structure and function is key to addressing cardiac pathophysiology.

Purpose of the Study:

  • To review current knowledge on cardiac ryanodine receptor structure and function.
  • To explore the role of RyR2 in cardiac pathophysiology, particularly in heart failure.
  • To discuss genetic diseases linked to RyR2 mutations and potential clinical applications.

Main Methods:

  • Review of existing literature on cardiac ryanodine receptor.
  • Analysis of RyR2's role in calcium regulation and excitation-contraction coupling.
  • Examination of RyR2 alterations in heart failure and genetic cardiac conditions.

Main Results:

  • In heart failure, chronic hyperadrenergic state leads to RyR2 hyperphosphorylation, causing calcium leakage.
  • This calcium leak impairs excitation-contraction coupling and contributes to reduced cardiac output.
  • RyR2 dysfunction is linked to delayed afterdepolarizations, potentially causing fatal arrhythmias.
  • Mutations in RyR2 are associated with arrhythmogenic right ventricular dysplasia type 2 and catecholaminergic polymorphic ventricular tachycardia.

Conclusions:

  • Cardiac ryanodine receptor plays a critical role in normal heart function and its dysfunction contributes to heart failure.
  • Therapeutic strategies targeting RyR2, such as beta-adrenergic blockade, can restore normal function.
  • Further research into RyR2 and its modulators holds promise for clinical applications in treating cardiac diseases.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...